Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT01769209 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-cell Adult Acute Lymphoblastic Leukemia (ALL)
Ph-positive Adult Acute Lymphoblastic Leukemia (ALL)
Recurrent Adult Acute Lymphoblastic Leukemia (ALL)
T-cell Adult Acute Lymphoblastic Leukemia (ALL)

Interventions

DRUG: Bortezomib
DRUG: Doxorubicin hydrochloride (HCl)
DRUG: PEG-Asparaginase
DRUG: Vincristine sulfate
DRUG: Dexamethasone
DRUG: Cytarabine
DRUG: Methotrexate

Sponsor

Stanford University

Collaborators

[object Object]